Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Müller

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cells|June 5, 2020
Orthotopic T-Cell Receptor Replacement-An "Enabler" for TCR-Based TherapiesKilian Schober, Thomas R Müller, Dirk H Busch
STAR Protocols|January 3, 2022
Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repairCarolin Moosmann, Thomas R Müller, Dirk H Busch, et al.
Psychiatrische Praxis|April 14, 2023
[The Journal "Deine Gesundheit" - A Reflection of Social Psychiatry in the GDR?]Thomas R Müller, Kathleen Haack, Hans Jörgen Grabe, et al.
Clinical & Translational Immunology|November 30, 2020
A T-cell reporter platform for high-throughput and reliable investigation of TCR function and biologyThomas R Müller, Corinna Schuler, Monika Hammel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2019
FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC MultimersManuel Effenberger, Andreas Stengl, Kilian Schober, et al.
Frontiers in Immunology|August 6, 2024
Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigenFawad Khan, Thomas R Müller, Bahram Kasmapour, et al.
Nature Biomedical Engineering|June 12, 2019
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell functionKilian Schober, Thomas R Müller, Füsun Gökmen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2025
Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieuCaroline Boulouis, Elli Mouchtaridi, Thomas R Müller, et al.
Scientific Reports|November 15, 2018
Efficient immunoaffinity chromatography of lymphocytes directly from whole bloodFabian Mohr, Sabine Przibilla, Franziska Leonhardt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trialCesare Gridelli, Eckhard Kaukel, Vanessa Gregorc, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cells|June 5, 2020
Orthotopic T-Cell Receptor Replacement-An "Enabler" for TCR-Based TherapiesKilian Schober, Thomas R Müller, Dirk H Busch
STAR Protocols|January 3, 2022
Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repairCarolin Moosmann, Thomas R Müller, Dirk H Busch, et al.
Psychiatrische Praxis|April 14, 2023
[The Journal "Deine Gesundheit" - A Reflection of Social Psychiatry in the GDR?]Thomas R Müller, Kathleen Haack, Hans Jörgen Grabe, et al.
Clinical & Translational Immunology|November 30, 2020
A T-cell reporter platform for high-throughput and reliable investigation of TCR function and biologyThomas R Müller, Corinna Schuler, Monika Hammel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2019
FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC MultimersManuel Effenberger, Andreas Stengl, Kilian Schober, et al.
Frontiers in Immunology|August 6, 2024
Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigenFawad Khan, Thomas R Müller, Bahram Kasmapour, et al.
Nature Biomedical Engineering|June 12, 2019
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell functionKilian Schober, Thomas R Müller, Füsun Gökmen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2025
Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieuCaroline Boulouis, Elli Mouchtaridi, Thomas R Müller, et al.
Scientific Reports|November 15, 2018
Efficient immunoaffinity chromatography of lymphocytes directly from whole bloodFabian Mohr, Sabine Przibilla, Franziska Leonhardt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trialCesare Gridelli, Eckhard Kaukel, Vanessa Gregorc, et al.
Pageof 3